Mr. Marbles was a beloved fixture of her YouTube channel and even made an appearance in her 2022 wedding photos Matthew Simmons/WireImage; Julien Solomita/Instagram Jenna Marbles’ dog Mr. Marbles has ...

The former YouTuber’s husband, Julien Solomita, shared the news on Instagram, writing, “mr. marbles. thank u for showing me what it truly means to ride or die. i love you almost as much as you loved ...

The tribute from Solomita was a rare personal update from the couple, given Jenna's departure from YouTube and public life in 2020. Jenna has remained mostly offline, but Mr. Marbles continued to make ...

Solomita, 33, took to Instagram on Friday and shared the sad news with his 1.3 million followers. Posting a single photo of the beloved chihuahua, he wrote in the caption, 'mr. marbles. thank u for ...

Solomita shared on Twitch on November 10 that the senior pup was receiving “end of life” care. He said at the time, “Mentally, I’m not fully here. Marbles is getting really old, so we’re dealing with ...

Engineer the marble run of your dreams. No need to get it perfect – just release your marbles and let the good times roll. Watch the latest Cozy Marbles trailer for this upcoming simulator game. In ...

Akero Therapeutics (AKRO) is catching the market’s eye after shares moved slightly higher this week, following a recent stretch of strong year-to-date gains. Investors are now keeping an eye on what ...

Stock futures edged lower on Thursday as investors turned cautious after Federal Reserve Chair Jerome Powell refrained from commenting on the economic outlook or monetary policy during a Fed event, ...

Novo Nordisk A/S (NYSE:NVO) is down 1% to trade at $59 this morning, after news surfaced that the pharmaceutical concern has entered an agreement to purchase U.S.-based peer Akero Therapeutics Inc ...

Marbles Kids Museum on Thursday released new renderings of its "Futuropolis" exhibit, opening in late 2026. The exhibit will highlight careers including construction, transportation, manufacturing and ...

Fintel reports that on August 4, 2025, TD Cowen initiated coverage of Akero Therapeutics (NasdaqGS:AKRO) with a Buy recommendation. Analyst Price Forecast Suggests 62.37% Upside As of July 17, 2025, ...